From pumps to prevention: recent advances in the treatment of type 1 diabetes

被引：7

作者：

Sherr, Jennifer ^{[1
,2
]}

Cengiz, Eda ^{[1
,2
]}

Tamborlane, William V. ^{[1
,2
]}

机构：

[1] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA

[2] Yale Univ, Sch Med, Yale Ctr Clin Investigat, New Haven, CT 06510 USA

来源：

DRUG DISCOVERY TODAY | 2009年 / 14卷 / 19-20期

基金：

美国国家卫生研究院;

关键词：

CONTINUOUS SUBCUTANEOUS INSULIN; ANTI-CD3; MONOCLONAL-ANTIBODY; MULTIPLE DAILY INJECTIONS; RANDOMIZED CONTROLLED-TRIAL; GLUCOSE MONITORING-SYSTEM; PLACEBO-CONTROLLED TRIAL; BONE-MINERAL DENSITY; QUALITY-OF-LIFE; GLYCEMIC CONTROL; PEDIATRIC-PATIENTS;

D O I：

10.1016/j.drudis.2009.06.011

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Treatment options for pediatric patients living with type 1 diabetes mellitus (T1DM) have drastically changed over the past 30 years. Technological advances including the development of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) have allowed for improved insulin delivery and a better understanding of blood glucose fluctuations. Manipulations of CSII and CGM will allow for the development of an artificial pancreas; initial studies of this technology will be reviewed. New medications for the treatment of T1DM have been developed, such as rapid-acting insulins. Another area of exploration is the autoimmune process that causes beta-cell destruction. Immunomodulators used for T1DM prevention and secondary intervention will be reviewed.

引用

收藏

页码：973 / 981

页数：9

相关论文

共 87 条

[51] Insulin pump therapy in youth with type 1 diabetes: A retrospective paired study [J].

Nimri, Revital ;

Weintrob, Naomi ;

Benzaquen, Hadassa ;

Ofan, Regina ;

Fayman, Gila ;

Phillip, Moshe .

PEDIATRICS, 2006, 117 (06) :2126-2131

[52] The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus [J].

Nyholm, B ;

Orskov, L ;

Hove, KY ;

Gravholt, CH ;

Moller, N ;

Alberti, KGMM ;

Moyses, C ;

Kolterman, O ;

Schmitz, O .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (07) :935-941

[53] Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus [J].

Opipari-Arrigan, Lisa ;

Fredericks, Emily M. ;

Burkhart, Nugget ;

Dale, Linda ;

Hodge, Mary ;

Foster, Carol .

PEDIATRIC DIABETES, 2007, 8 (06) :377-383

[54]

Pankowska Ewa, 2005, Diabetes Technol Ther, V7, P308, DOI 10.1089/dia.2005.7.308

[55] Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials [J].

Pankowska, Ewa ;

Blazik, Marlena ;

Dziechciarz, Piotr ;

Szypowska, Agnieszka ;

Szajewska, Hania .

PEDIATRIC DIABETES, 2009, 10 (01) :52-58

[56] Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system [J].

Panteleon, Antonios E. ;

Loutseiko, Mikhail ;

Steil, Garry M. ;

Rebrin, Kerstin .

DIABETES, 2006, 55 (07) :1995-2000

[57] Use of insulin pediatric pump therapy in the age-group - Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes [J].

Phillip, Moshe ;

Battelino, Tadej ;

Rodriguez, Henry ;

Danne, Thomas ;

Kaufman, Francine .

DIABETES CARE, 2007, 30 (06) :1653-1662

[58] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION - APPROACH TO ACHIEVING NORMOGLYCAEMIA [J].

PICKUP, JC ;

KEEN, H ;

PARSONS, JA ;

ALBERTI, KGMM .

BRITISH MEDICAL JOURNAL, 1978, 1 (6107) :204-207

[59] Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes [J].

Plotnick, LP ;

Clark, LM ;

Brancati, FL ;

Erlinger, T .

DIABETES CARE, 2003, 26 (04) :1142-1146

[60] Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial [J].

Ratner, RE ;

Dickey, R ;

Fineman, M ;

Maggs, DG ;

Shen, L ;

Strobel, SA ;

Weyer, C ;

Kolterman, OG .

DIABETIC MEDICINE, 2004, 21 (11) :1204-1212

← 1 2 3 4 5 6 7 8 9 →